Pacific Biosciences Of California (PACB) Other Operating Expenses (2015 - 2026)

Pacific Biosciences Of California's Other Operating Expenses history runs 8 years deep, the most recent figure standing at $45.8 million for Q1 2026.

• In Q1 2026, Other Operating Expenses changed N/A year-over-year to $45.8 million; the TTM figure through Mar 2026 stood at $40.4 million (down 78.22% YoY), while the FY2025 annual figure was $347.9 million, up 85.14% from the prior year.
• Other Operating Expenses was $45.8 million for Q1 2026 at Pacific Biosciences Of California, up from -$1.9 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $93.9 million in Q2 2024 to a low of -$7.8 million in Q2 2022.
• Historically, Other Operating Expenses has averaged $14.4 million across 5 years, with a median of $1.3 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Other Operating Expenses soared 11098.01% in 2024, then tumbled 360.06% in 2025.
• A 5-year view of Other Operating Expenses shows it stood at $2.1 million in 2022, then soared by 72.26% to $3.5 million in 2023, then surged by 2474.49% to $91.1 million in 2024, then plunged by 102.09% to -$1.9 million in 2025, then surged by 2506.52% to $45.8 million in 2026.
• The last three Other Operating Expenses figures came in at $45.8 million (Q1 2026), -$1.9 million (Q4 2025), and -$1.6 million (Q3 2025), per Business Quant data.